CA Patent

CA2546797A1 — Use of substituted 2-aminotetralines for the preventative treatment of parkinson's disease

Assigned to UCB Pharma GmbH · Expires 2005-07-14 · 21y expired

What this patent protects

The invention relates to the use of substituted 2-aminotetralins of general formula (I) as a medicament for the preventive treatment of Parkinson's disease.

USPTO Abstract

The invention relates to the use of substituted 2-aminotetralins of general formula (I) as a medicament for the preventive treatment of Parkinson's disease.

Drugs covered by this patent

Patent Metadata

Patent number
CA2546797A1
Jurisdiction
CA
Classification
—
Expires
2005-07-14
Drug substance claim
No
Drug product claim
No
Assignee
UCB Pharma GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.